Applications are invited for three-year PhD studentships to be funded by the Marie- Skłodowska-Curie Innovative Training Network “BactiVax” within the Horizon 2020 Programme of the European Commission. BactiVax (anti-Bacterial Innovative Vaccines) is a European Training Network that will provide high-level training in vaccinology to high-achieving, creative Early Stage Researchers (ESRs), and equip them with a wide range of transferable skills for thriving careers in vaccine research within academia and industry.
BactiVax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening respiratory and/or systemic infections. This network comprises researchers with expertise in vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, medicinal, peptide and glycochemistry and the successful candidates will receive training in entrepreneurship, commercial vaccine development and bioprocessing.
We are looking for talented and highly motivated early career applicants with an Honours BSc and/or MSc degree and experience in biology, infection & immunity, biochemistry, microbiology, pharmacology, organic synthesis, glycochemistry, drug delivery or related subjects.
Further details about BactiVax can be found here: https://www.bactivax.eu/opportunities
Please note that all criteria below are mandatory:
• Applicants should, at the time of recruitment, be in the first four years (full time equivalent research experience) of their research careers and not have been awarded a doctorate.
• At the time of recruitment by the host organisation, they must not have resided or carried out their main activity (work, studies, etc.) in the country of their host organisation for more than 12 months in the 3 years immediately prior to the recruitment date. Compulsory national service, short stays such as holidays, and time spent as part of a procedure for obtaining refugee status under the Geneva Convention are not taken into account.
• Admission to the programme is open to applicants who hold a bachelor’s and/or Master’s degree. The degrees must be obtained by the time of recruitment.
• Requirements set by the consortium include a minimum of BSc Honours 2.1 and/or MSc degree (or equivalent) graduates in the fields of chemistry, medicinal chemistry, pharmacology, biochemistry, biology, microbiology, biomedical and biopharmaceutical sciences, medicine.
• Applicants should be proficient in written and spoken English (minimum level of B2 or equivalent). Those who have passed an English proficiency test such as (but not limited to) IELTS Academic or TOEFL should enclose the relevant certificate with their application. English proficiency of short-listed applicants will be assessed during the selection interview.